Characterising polymyalgia rheumatica on whole-body 18F-FDG PET/CT: an atlas-Reference-Cited by-同舟云学术

Characterising polymyalgia rheumatica on whole-body 18F-FDG PET/CT: an atlas

Published:2023-12-09 Issue:1 Volume:8 Page:
ISSN:2514-1775
Container-title:Rheumatology Advances in Practice
language:en
Short-container-title:

Author:

Owen Claire E¹²^ORCID,Poon Aurora M T³,Liu Bonnia¹,Liew David F L¹²^ORCID,Yap Lee Pheng⁴,Yang Victor¹^ORCID,Leung Jessica L¹²,McMaster Christopher R¹²^ORCID,Scott Andrew M²³⁵,Buchanan Russell R C¹²

Affiliation:

1. Department of Rheumatology, Austin Health , Heidelberg, Victoria, Australia

2. Department of Medicine, University of Melbourne , Parkville, Victoria, Australia

3. Department of Molecular Imaging and Therapy, Austin Health , Heidelberg, Victoria, Australia

4. Department of Radiology, Austin Health , Heidelberg, Victoria, Australia

5. Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University , Melbourne, Victoria, Australia

Abstract

Abstract The impact of modern imaging in uncovering the underlying pathology of PMR cannot be understated. Long dismissed as an inflammatory syndrome with links to the large vessel vasculitis giant cell arteritis (GCA), a pathognomonic pattern of musculotendinous inflammation is now attributed to PMR and may be used to confirm its diagnosis. Among the available modalities, 18F-fluorodeoxyglucose (18F-FDG) PET/CT is increasingly recognized for its high sensitivity and specificity, as well as added ability to detect concomitant large vessel GCA and exclude other relevant differentials like infection and malignancy. This atlas provides a contemporary depiction of PMR’s pathology and outlines how this knowledge translates into a pattern of findings on whole body 18F-FDG PET/CT that can reliably confirm its diagnosis.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/rheumap/article-pdf/8/1/rkae003/56700134/rkae003.pdf

Reference45 articles.

1. Musculotendinous inflammation: the defining pathology of polymyalgia rheumatica?;Owen;J Rheumatol,2019

2. Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica;van der Geest;Rheumatology (Oxford),2021

3. Strathpeffer Spa: Dr William Bruce and polymyalgia rheumatica;Mowat;Ann Rheum Dis

4. Ultrasonographic evidence of synovitis in axial joints in patients with polymyalgia rheumatica;Koski;Br J Rheumatol,1992

5. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment;Meliconi;Arthritis Rheumatol,1996

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neues in der Bildgebung von Großgefäßvaskulitiden;Zeitschrift für Rheumatologie;2024-09-13

2. Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6;Rheumatology Science and Practice;2024-09-02

3. Polymyalgia rheumatica – Was gibt es Neues?;DMW - Deutsche Medizinische Wochenschrift;2024-08

4. Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What—A Critical Review;Diagnostics;2024-07-17

5. Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomization;Rheumatology;2024-05-24